Poll Results: Is Psychiatry Doing Enough to Address Federal Doubt of the Field?

Author(s):

Key Takeaways

Executive Order 14212 mandates risk assessment of psychotropic medications, including SSRIs, antipsychotics, mood stabilizers, and stimulants.
Psychiatric organizations counter concerns that could lead to misinformation and reduced access to evidence-based treatments.
The field of psychiatry faces questions about its response to federal skepticism and the impact on practice.
Professionals are encouraged to share their perspectives and contribute to discussions on federal policies affecting psychiatry.

We asked our readers if they thought psychiatry is doing enough to address federal doubt. Here's how they responded.

Last month, leading psychiatric organizations addressed Executive Order 14212 in a large joint statement, which called for an assessment of the risks associated with psychotropic medications, including selective serotonin reuptake inhibitors (SSRIs), antipsychotics, mood stabilizers, and stimulants. The statement pushed back against concerns that could lead to misinformation and reduced access to evidence-based treatments. You can read the entire statement and view additional exclusive commentary from Joseph F. Goldberg, MD, here.

Following this statement, we asked you if psychiatry is doing enough to address federal doubt of the field. Here is how you all responded.

Question: Is psychiatry doing enough to address federal doubt of the field?

Approximately 8.2% said "yes," 20.2% said "I'm not sure," and a whopping 71.7% said "no."

Do these results surprise you? Would you like to share your opinion? If you are interested in writing on this topic, please email us at PTEditor@mmhgroup.com!